| pubmed-article:20172140 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C0033680 | lld:lifeskim |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C0054201 | lld:lifeskim |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C0190010 | lld:lifeskim |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:20172140 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:20172140 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20172140 | pubmed:dateCreated | 2010-2-22 | lld:pubmed |
| pubmed-article:20172140 | pubmed:abstractText | Intestinal inflammation is a component of the pathophysiology of protein-losing enteropathy after the Fontan operation. Oral controlled-release budesonide is 90% metabolized at first pass through the liver, has high enteric anti-inflammatory activity and relatively low systemic effects, and may be an ideal agent for use in treating this disease. | lld:pubmed |
| pubmed-article:20172140 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20172140 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20172140 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:20172140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20172140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20172140 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20172140 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20172140 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20172140 | pubmed:issn | 1552-6259 | lld:pubmed |
| pubmed-article:20172140 | pubmed:author | pubmed-author:GoldbergDavid... | lld:pubmed |
| pubmed-article:20172140 | pubmed:author | pubmed-author:RychikJackJ | lld:pubmed |
| pubmed-article:20172140 | pubmed:author | pubmed-author:SemeaoEdisioE | lld:pubmed |
| pubmed-article:20172140 | pubmed:author | pubmed-author:ThackerDeepik... | lld:pubmed |
| pubmed-article:20172140 | pubmed:author | pubmed-author:PatelAkashA | lld:pubmed |
| pubmed-article:20172140 | pubmed:author | pubmed-author:DoddsKathrynK | lld:pubmed |
| pubmed-article:20172140 | pubmed:copyrightInfo | 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:20172140 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20172140 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:20172140 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20172140 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20172140 | pubmed:pagination | 837-42 | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:meshHeading | pubmed-meshheading:20172140... | lld:pubmed |
| pubmed-article:20172140 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20172140 | pubmed:articleTitle | Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. | lld:pubmed |
| pubmed-article:20172140 | pubmed:affiliation | Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. | lld:pubmed |
| pubmed-article:20172140 | pubmed:publicationType | Journal Article | lld:pubmed |
